AAAAAA

   
Results: 1-10 |
Results: 10
PREVENTION OF VIRUS EPIDEMICS BY A CROP-FREE PERIOD IN THE ARAVA REGION OF ISRAEL
Authors: UCKO O COHEN S BENJOSEPH R
Citation: O. Ucko et al., PREVENTION OF VIRUS EPIDEMICS BY A CROP-FREE PERIOD IN THE ARAVA REGION OF ISRAEL, Phytoparasitica, 26(4), 1998, pp. 313-321
TOLERANCE TO CUCUMBER MOSAIC-VIRUS IN PEPPER - DEVELOPMENT OF ADVANCED BREEDING LINES AND EVALUATION OF VIRUS LEVEL
Authors: LAPIDOT M PARAN I BENJOSEPH R BENHARUSH S PILOWSKY M COHEN S SHIFRISS C
Citation: M. Lapidot et al., TOLERANCE TO CUCUMBER MOSAIC-VIRUS IN PEPPER - DEVELOPMENT OF ADVANCED BREEDING LINES AND EVALUATION OF VIRUS LEVEL, Plant disease, 81(2), 1997, pp. 185-188
COST OF ACID PEPTIC DISORDERS IN A MANAGED-CARE ORGANIZATION
Authors: SEGAL R RUSSELL WL BENJOSEPH R MANSHEIM B
Citation: R. Segal et al., COST OF ACID PEPTIC DISORDERS IN A MANAGED-CARE ORGANIZATION, Clinical therapeutics, 18(2), 1996, pp. 319-333
EVALUATING THE VALUE, ACCURACY, AND OPERATIONAL FEASIBILITY OF DUE CRITERIA
Authors: BENJOSEPH R SEGAL R RUSSELL WL OH T
Citation: R. Benjoseph et al., EVALUATING THE VALUE, ACCURACY, AND OPERATIONAL FEASIBILITY OF DUE CRITERIA, Formulary, 30(5), 1995, pp. 280-283
LISIANTHUS LEAF CURL A NEW DISEASE OF LISIANTHUS CAUSED BY TOMATO YELLOW LEAF CURL VIRUS
Authors: COHEN J GERA A ECKER R BENJOSEPH R PERLSMAN M GOKKES M LACHMAN O ANTIGNUS Y
Citation: J. Cohen et al., LISIANTHUS LEAF CURL A NEW DISEASE OF LISIANTHUS CAUSED BY TOMATO YELLOW LEAF CURL VIRUS, Plant disease, 79(4), 1995, pp. 416-420
FIRST REPORT OF BELL-SHAPED PEPPERS TOLERANT TO CUCUMBER MOSAIC-VIRUS
Authors: SHIFRISS VC PILOWSKI M COHEN S BENJOSEPH R BENHARUSH S
Citation: Vc. Shifriss et al., FIRST REPORT OF BELL-SHAPED PEPPERS TOLERANT TO CUCUMBER MOSAIC-VIRUS, Plant disease, 78(9), 1994, pp. 925-925
PHARMACOECONOMIC MEANS MORE THAN PRICE - REPLY
Authors: SEGAL R OH T BENJOSEPH R RUSSELL WL
Citation: R. Segal et al., PHARMACOECONOMIC MEANS MORE THAN PRICE - REPLY, Hospital formulary, 29(9), 1994, pp. 607-608
A PHARMACOECONOMIC ANALYSIS OF IV H-2-RECEPTOR ANTAGONIST USE IN 40 HOSPITALS
Authors: SEGAL R OH TH BENJOSEPH R RUSSELL WL
Citation: R. Segal et al., A PHARMACOECONOMIC ANALYSIS OF IV H-2-RECEPTOR ANTAGONIST USE IN 40 HOSPITALS, Hospital formulary, 29(5), 1994, pp. 379
RISK FOR ADVERSE EVENTS AMONG PATIENTS RECEIVING INTRAVENOUS HISTAMINE(2)-RECEPTOR ANTAGONISTS
Authors: BENJOSEPH R SEGAL R RUSSELL WL
Citation: R. Benjoseph et al., RISK FOR ADVERSE EVENTS AMONG PATIENTS RECEIVING INTRAVENOUS HISTAMINE(2)-RECEPTOR ANTAGONISTS, The Annals of pharmacotherapy, 27(12), 1993, pp. 1532-1537
USE OF IV CIMETIDINE, RANITIDINE, AND FAMOTIDINE IN 40 HOSPITALS
Authors: SEGAL R RUSSELL WL OH T BENJOSEPH R
Citation: R. Segal et al., USE OF IV CIMETIDINE, RANITIDINE, AND FAMOTIDINE IN 40 HOSPITALS, American journal of hospital pharmacy, 50(10), 1993, pp. 2077-2081
Risultati: 1-10 |